ZEB1 and breast cancer: Extensive alternative splicing occurs during EMT, in part mediated by ZEB1, which transcriptionally represses the epithelial splicing regulatory protein genes, favoring expression of spliced isoforms of the FGF receptors that help maintain EMT in breast cancer cells in response to TGFβ (Horiguchi et al., 2012).